AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. – Trademark Portfolio
Entity Type: 03
AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. The owner is based in BETHESDA, MD.
7272 WISCONSIN AVENUE
BETHESDA, MD 20814
Showing of trademarks Trademarks
Trademark Classifications
AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. have?
AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. has 1 U.S. trademark filed with the USPTO.
What trademark classes does AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. file in?
AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What is AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC.'s trademark registration success rate?
AMERICAN SOCIETY OF HOSPITAL PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, INC. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.